GO
Loading...

Medtronic Inc

More

  • LONDON, June 20- British drugmaker Shire has rejected a 27 billion-pound takeover offer from AbbVie, the latest attempt by a U.S. healthcare firm to tap into the London- listed group's low tax rate. Abbvie's takeover offer proposed creating a new U.S.-listed holding company with a UK tax domicile in a so-called "inversion" move.

  • Why Minnesota policymakers revamped biz taxes Wednesday, 18 Jun 2014 | 2:07 PM ET
    Dirk Bak

    If there is a silver lining to Minnesota's current business climate, it's that the legislature was forced to repeal biz sales taxes.

  • WASHINGTON, June 17- U.S. medical device maker Medtronic's plan to buy rival Covidien and move its base to Ireland is a sign that something is wrong with the U.S. tax system, a top Obama administration official said on Tuesday.

  • WASHINGTON, June 17- The U.S. Senate's chief tax law writer on Tuesday vowed to work on overhauling the federal tax code by August 2015, citing a move by Medtronic Inc to shift its tax home base to Ireland as a spur to congressional action.

  • WASHINGTON, June 17- The U.S. Senate's chief tax law writer on Tuesday vowed to work on overhauling the federal tax code by August 2015, citing a move by Medtronic Inc to shift its tax home base to Ireland as a spur to congressional action.

  • Multiple analysts upgrade Medtronic     Tuesday, 17 Jun 2014 | 9:30 AM ET

    CNBC's David Faber and Jim Cramer dig into upgrades for Medtronic from multiple analysts after the company announced it was buying Covidien.

  • *Shire expecting to receive approaches, taps Citi- sources. LONDON, June 17- Shares in Shire hit a record high on Tuesday on expectations of a takeover as dealmaking sweeps the drugs sector, after Reuters reported the group had hired investment bank Citi as a defence adviser. Shire and Citi declined to comment.

  • *Alstom extends fall after Siemens/ Mitsubishi bid. U.S. medical device maker Medtronic agreed earlier this week to buy Dublin- based Covidiuen. "Shire have been perennial potential bid candidate for years now," said Jeremy Batstone-Carr, a research analyst at Charles Stanley.

  • WASHINGTON, June 16- The threat of U.S. tax revenue losses from Medtronic Inc's plan to buy rival Covidien Plc and move its base to Ireland is stoking concerns from lawmakers and the Obama administration about corporate tax "inversion" deals.

  • June 16- Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

  • Cramer: Perfectly legal strategy for ducking taxes Monday, 16 Jun 2014 | 6:21 PM ET

    If anyone hates high taxes, it’s Jim Cramer. And he’s always looking for new ways to do something about them.

  • CHICAGO, June 16- Well before Medtronic Inc and Covidien Plc announced their $43 billion merger, the two medical device makers had reached common conclusions about how they needed to change. U.S.-based Medtronic on Sunday said it would buy Covidien and moving its executive headquarters to Ireland to take advantage of lower corporate tax rates.

  • WASHINGTON, June 16- The threat of U.S. tax revenue losses from Medtronic Inc's plan to buy rival Covidien Plc and move its base to Ireland is stoking concerns from lawmakers and the Obama administration about corporate tax "inversion" deals.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • Stocks end slightly higher as M&A, data offset Iraq Monday, 16 Jun 2014 | 4:54 PM ET
    A trader works on the floor of the New York Stock Exchange.

    U.S. stocks wavered on Monday on strife in Iraq.

  • *Medtronic to buy Covidien for $42.9 bln. *U.S. considering talks with Iran over Iraq. NEW YORK, June 16- U.S. stocks closed slightly higher on Monday, supported by a flurry of merger news, but turmoil in Iraq drove oil prices up and kept trading choppy.

  • *Medtronic to buy Covidien for $42.9 bln. *U.S. considering talks with Iran over Iraq. NEW YORK, June 16- U.S. stocks edged higher on Monday afternoon, reversing a midday dip, supported by a flurry of merger news, but the advance was limited as investors kept a close watch on rising oil prices caused by turmoil in Iraq.

  • Shire braces for takeover bids, hires Citi: Sources Monday, 16 Jun 2014 | 2:25 PM ET
    Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc.

    Shire has hired investment bank Citi as an adviser following a wave of deals in the healthcare sector.

  • Analyzing Medtronic-Covidien deal     Monday, 16 Jun 2014 | 2:21 PM ET

    Medtronic bought Covidien for $42.9 billion. Shagun Chadha, CRT Capital Group, discusses what this means for investors and explains the tax savings component of the transaction.

  • LONDON, June 16- London- listed drugmaker Shire has hired investment bank Citi as an adviser, expecting to receive takeover approaches following a wave of deals in the healthcare sector, sources familiar with the matter told Reuters.